Clinical Trials Logo

Prediabetic State clinical trials

View clinical trials related to Prediabetic State.

Filter by:

NCT ID: NCT03785951 Not yet recruiting - Pre Diabetes Clinical Trials

Impact of Whey and Leucine on Glycaemia in Adults Without Diabetes

Whey2Glo
Start date: December 2018
Phase: N/A
Study type: Interventional

Higher than average blood sugar (glucose) levels are linked to an increased risk of developing type 2 diabetes. As such, there is interest in identifying dietary factors that could lower blood glucose to help reduce the number of people with this disease. Findings from some human studies indicate that dairy products, especially a milk protein (whey), may help the control of blood glucose levels. However, there is a need for further studies to confirm these findings in individuals without diabetes but with higher than average blood glucose levels.

NCT ID: NCT03781102 Suspended - Type 2 Diabetes Clinical Trials

Type 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and Mothers

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The two main questions that this research study will answer: 1. will a 16-week community-based diabetes prevention program for delivery to at-risk mothers and children in a Federally Qualified Health Center (FQHC) setting show (a) pre- and post-intervention improvements to Type 2 Diabetes risk factors in 60 mother-child dyads; (b) intervention vs. control improvements to T2D risk factors in 30 mother-child dyads; and (c) maintenance effects to changes to Type 2 Diabetes risk factors in 30 mother-child dyads; and 2. based on the acceptability, adoption, relevance to FQHC and participants, feasibility, fidelity, program costs, and factors influencing sustainability of this program, can it be disseminated nationwide to other FQHC's? The investigators hypothesize that participants (a) will show improvements following the intervention to T2D risk factors, (b) in the intervention will show significant improvements to T2D risk factors in versus the controls, and (c) will maintain the benefits beyond the 16-week intervention. The investigators also predict that this program will meet criteria to be disseminated nationwide to other FQHC's.

NCT ID: NCT03774108 Active, not recruiting - PreDiabetes Clinical Trials

Metformin and Systemic Inflammation in HIV

Metfo
Start date: December 15, 2018
Phase: Phase 4
Study type: Interventional

The purposes of this study are to find out if: metformin can be combined with anti-HIV drugs to reduce systemic inflammation measured by the determination of cytokines and other series of serum markers. To determine if the concomitant administration of metformin with TARA improves the immune function on the CD4 T cell count and its relation with the CD8 T cells, during the treatment and after its interruption. To this end, in the present study, patients with prediabetes (who meet the fasting impaired glucose criteria) will be identified and treated with metformin or placebo for 8 weeks, receiving stable TARA and with a CD4 + level> 200 cells / μL. 40 patients from the HIV Unit of the Civil Hospital of Guadalajara "Fray Antonio Alcalde" will be included in this study and the intervention will last 8 weeks.

NCT ID: NCT03773731 Recruiting - Prediabetic State Clinical Trials

High Intensity Interval Training in Prediabetes

Start date: January 4, 2019
Phase: N/A
Study type: Interventional

This trial investigates if high intensity interval training is more effective than moderate intensity continuous training in suppressing platelet reactivity and hepatic fat content in prediabetic individuals.

NCT ID: NCT03771261 Completed - Obesity Clinical Trials

Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race

EGGSPDITe
Start date: June 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (with substantial amounts provided from whole eggs and egg whites) with calorie restriction on insulin resistance and weight loss (along with function, body composition, racial disparities, and a number of secondary outcomes) in black and white older adults with prediabetes who are participating in a 4-month intervention. The investigators will compare these effects to the same outcomes with a control group consuming a traditional control regimen of calorie restriction over the same duration.

NCT ID: NCT03761446 Recruiting - Type 2 Diabetes Clinical Trials

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

REST
Start date: March 18, 2019
Phase: N/A
Study type: Interventional

The goal of this study is to determine the impact of pre-diabetes and type 2 diabetes on muscle atrophy during a period of bed rest and recovery of muscle mass, strength, and physical function following bed rest.

NCT ID: NCT03737422 Completed - PreDiabetes Clinical Trials

The Effects of Hesperidin and Flaxseed in Prediabetes

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To study the effects of Hesperidin and flaxseed supplement in patients with prediabetes, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin and 30 gram flaxseed for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.

NCT ID: NCT03733743 Completed - Clinical trials for Diabetes Mellitus, Type 2

Day-night Rhythm in Muscle Metabolism of Prediabetics

Start date: July 9, 2018
Phase: N/A
Study type: Interventional

This study evaluates the existence of a day-night rhythm in skeletal muscle energy metabolism in prediabetic subjects. Subjects will stay at the research facility for 44 hours with a standardized living protocol during which several measurements of skeletal muscle and whole body energy metabolism will be performed.

NCT ID: NCT03729479 Completed - Hypertension Clinical Trials

The MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online)

Start date: November 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This study will compare the low-sodium/low-fat DASH (Dietary Approaches to Stop Hypertension) diet with a very low-carbohydrate diet, helping us to better understand how two different dietary approaches may help participants control their blood pressure, lose weight, and reduce their blood glucose.

NCT ID: NCT03721874 Completed - Prediabetic State Clinical Trials

Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

MaasFlex
Start date: April 30, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effect of 2 weeks dapagliflozin treatment in individuals with a disrupted glucose homeostasis on the switch between carbohydrate and lipid oxidation during the night